Clinical Trial

geniculaR Artery eMBolization for Knee Osteoarthritis (RAMBO) Registry

Study acronym: RAMBO
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study (prospective registry) is to collect long-term real-world data on the effectiveness and safety of genicular artery embolization (GAE) for knee osteoarthritis in adults aged 18 years or older with symptomatic KOA that has not responded to medical therapy. The main questions it aims to answer are: 1. Does GAE lead to sustained improvement in pain (WOMAC, VAS) and quality-of-life scores over 12-36 months? 2. What patient or procedural factors are associated with better outcomes after GAE? Participants will: * Undergo GAE as part of their routine clinical care. * Complete clinical follow-up assessments at 1, 3, 6, 12, 18, 24, and 36 months after treatment, including symptom and quality-of-life questionnaires. * Have safety outcomes tracked according to Society of Interventional Radiology guidelines. There is no comparison group; results will be analyzed to identify predictors of success and inform best practices for patient selection and treatment.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-01-24; most recent amendment 2026-06-10.
Trial Details
NCT Number NCT07380906
Lead Sponsor Joint & Vascular Institute
Conditions Knee Osteoarthristis
Enrollment 1,200 participants
Start Date 2025-07-16
Primary Completion 2030-04 (estimated)
Study Completion 2030-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-12